NASDAQ:BBH VanEck Biotech ETF - BBH Short Interest Ratio & Short Volume Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding VanEck Biotech ETF Please log in to your account or sign up in order to add this asset to your watchlist. $157.81 -0.35 (-0.22%) (As of 03/27/2023 12:00 AM ET) Add Compare Share Share Today's Range$157.81▼$158.9650-Day Range$151.32▼$164.7752-Week Range$131.12▼$170.25Volume6,304 shsAverage Volume10,557 shsMarket Capitalization$489.21 millionAssets Under Management$481.70 millionDividend Yield0.48%Net Expense Ratio0.35% ProfileChartDividendInstitutional OwnershipHeadlinesHoldingsOptions ChainShort InterestSocial Media VanEck Biotech ETF Short Interest DataCurrent Short Volume2,300 sharesPrevious Short Volume2,200 sharesChange Vs. Previous Month+4.55%Dollar Volume Sold Short$360,479.00Short Interest Ratio / Days to Cover0.2Last Record DateMarch 15, 2023Outstanding Shares3,100,000 sharesPercentage of Shares Shorted0.07%Today's Trading Volume6,304 sharesAverage Trading Volume10,557 sharesToday's Volume Vs. Average-40.29% Short Selling VanEck Biotech ETF ? Sign up to receive the latest short interest report for VanEck Biotech ETF and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatBBH Short Interest Over TimeBBH Days to Cover Over TimeBBH Percentage of Float Shorted Over Time VanEck Biotech ETF (NASDAQ:BBH) Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/20232,300 shares $360,479.00 +4.6%N/A0.2 $156.73 2/28/20232,200 shares $343,838.00 -74.1%N/A0.2 $156.29 2/15/20238,500 shares $1.40 million -38.0%N/A0.7 $164.77 1/31/202313,700 shares $2.30 million -38.6%N/A1 $167.74 1/15/202322,300 shares $3.75 million -9.0%N/A1.6 $168.27 12/30/202224,500 shares $3.91 million -9.9%N/A1.9 $159.74 12/15/202227,200 shares $4.51 million +115.9%N/A2 $165.75 11/30/202212,600 shares $2.12 million +106.6%N/A1 $168.16 11/15/20226,100 shares $1.02 million -80.7%N/A0.5 $166.95 10/31/202231,600 shares $4.97 million +182.1%N/A2.4 $157.23 10/15/202211,200 shares $1.63 million No ChangeN/A0.8 $145.46 9/30/20227,500 shares $1.06 million -33.6%N/A0.5 $140.78 9/15/202211,300 shares $1.67 million +41.3%N/A0.7 $147.60 8/31/20228,000 shares $1.17 million -7.0%N/A0.4 $145.98 8/15/20228,600 shares $1.41 million -1.2%N/A0.4 $163.51 7/31/20228,700 shares $1.34 million -44.9%N/A0.3 $154.31 7/15/202215,800 shares $2.41 million -63.3%N/A0.6 $152.63 6/30/202243,100 shares $6.28 million +698.2%N/A1.7 $145.79 6/15/20225,400 shares $734,292.00 +12.5%N/A0.2 $135.98 5/31/20224,800 shares $710,352.00 -61.9%N/A0.2 $147.99 5/15/202212,600 shares $1.80 million -4.6%N/A0.6 $143.14 4/30/202213,200 shares $1.93 million -2.9%N/A0.6 $146.38 4/15/202213,600 shares $2.24 million +18.3%N/A0.6 $164.50 3/31/202211,500 shares $1.86 million -24.3%N/A0.5 $162.13 3/15/202215,200 shares $2.27 million -20.8%N/A0.6 $149.67 2/28/202219,200 shares $3.02 million -27.6%N/A0.7 $157.06 2/15/202226,500 shares $4.24 million -9.6%N/A1 $160.10 1/31/202229,300 shares $4.83 million +67.4%N/A1.2 $164.90 1/15/202217,500 shares $3.04 million -10.7%N/A0.8 $173.62 12/31/202119,600 shares $3.71 million +67.5%N/A1 $189.34 12/15/202111,700 shares $2.24 million -44.0%N/A0.6 $191.44 11/30/202120,900 shares $4.09 million -4.1%N/A1.2 $195.79 11/15/202121,800 shares $4.15 million +28.2%N/A1.4 $190.45 10/29/202117,000 shares $3.39 million -8.1%N/A1.1 $199.50 10/15/202118,500 shares $3.60 million -36.6%N/A1.2 $194.82 9/30/202129,200 shares $5.90 million +9.4%N/A1.8 $202.14 9/15/202126,700 shares $5.75 million -11.6%N/A1.8 $215.28 8/31/202130,200 shares $6.53 million -7.7%N/A2 $216.12 8/13/202132,700 shares $6.93 million +144.0%N/A2 $212.07 7/30/202113,400 shares $2.77 million -0.7%N/A0.8 $206.99 BBH Short Interest - Frequently Asked Questions What is VanEck Biotech ETF's current short interest? Short interest is the volume of VanEck Biotech ETF shares that have been sold short but have not yet been closed out or covered. As of March 15th, traders have sold 2,300 shares of BBH short. Learn More on VanEck Biotech ETF's current short interest. Is VanEck Biotech ETF's short interest increasing or decreasing? VanEck Biotech ETF saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 2,300 shares, an increase of 4.5% from the previous total of 2,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does VanEck Biotech ETF's short interest compare to its competitors? Here is how the short interest of companies compare to VanEck Biotech ETF: Invesco S&P SmallCap Health Care ETF (0.04%), VanEck Pharmaceutical ETF (36.70%), First Trust Nasdaq Pharmaceuticals ETF (0.61%), ProShares UltraShort Nasdaq Biotechnology (8.64%), and iShares Biotechnology ETF (14.12%). Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Canadian Natural Resources Limited ($3.66 billion), Occidental Petroleum Co. ($2.62 billion), Coinbase Global, Inc. ($2.38 billion), T. Rowe Price Group, Inc. ($2.13 billion), Verisk Analytics, Inc. ($2.08 billion), Snowflake Inc. ($1.95 billion), Paramount Global ($1.78 billion), Etsy, Inc. ($1.60 billion), Teck Resources Limited ($1.51 billion), and Voya Financial, Inc. ($1.49 billion). View all of the most shorted stocks. What does it mean to sell short VanEck Biotech ETF stock? Short selling BBH is an investing strategy that aims to generate trading profit from VanEck Biotech ETF as its price is falling. BBH shares are trading down $0.35 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against VanEck Biotech ETF? A short squeeze for VanEck Biotech ETF occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BBH, which in turn drives the price of the stock up even further. How often is VanEck Biotech ETF's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BBH, twice per month. The most recent reporting period available is March, 15 2023. More Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BBH) was last updated on 3/27/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.